Lifestream Privalink Personalizes Cardiac Risk Assessment Via Internet
This article was originally published in The Gray Sheet
Executive Summary
Lifestream Technologies plans to launch by March its Privalink system, integrating testing of total cholesterol with encrypted data transfer and record storage via the Internet.
You may also be interested in...
Cholestech Looks To Capitalize On Possible OTC Switch For Cholesterol Drugs
Cholestech is poised to ink a cosponsorship agreement with J&J/Merck for its Cholestech L.D.X. in vitro diagnostic should the drug partnership's Mevacor be cleared for over-the-counter use to reduce cholesterol.
Cholestech Looks To Capitalize On Possible OTC Switch For Cholesterol Drugs
Cholestech is poised to ink a cosponsorship agreement with J&J/Merck for its Cholestech L.D.X. in vitro diagnostic should the drug partnership's Mevacor be cleared for over-the-counter use to reduce cholesterol.
Lifestream Technologies
Firm's point-of-care Cholesterol Monitor receives a CPT code from the American Medical Association allowing physicians to receive reimbursement for the test effective Jan. 1, 2001, Lifestream reports. Cleared via 510(k) in October 1998, the hand-held instrument provides total cholesterol levels in three minutes and links to the firm's Privalink Internet technology database, cleared Jan. 11 (1"The Gray Sheet" Jan. 24, p. 14) to provide personalized diagnostic and prognostic recommendations. The firm submitted a 510(k) for a consumer version of the monitor Feb. 29